Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Medigus Ltd.

    NASDAQ: MDGS · Real-Time Price · USD
    2.36
    0.22 (10.28%)
    At close: Apr 17, 2024, 10:00 PM

    Medigus Statistics

    Share Statistics

    Medigus has 1.89M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 1.89M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 25.52M

    Failed to Deliver (FTD) Shares

    n/a
    		 15

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 7K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.34 and the forward PE ratio is null. Medigus's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.34

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.06

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.23

    P/FCF Ratio

    n/a
    		 -0.69

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Medigus.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.42.

    Current Ratio

    n/a
    		 1.08

    Quick Ratio

    n/a
    		 1

    Debt / Equity

    n/a
    		 0.42

    Debt / EBITDA

    n/a
    		 -0.76

    Debt / FCF

    n/a
    		 -1.22

    Interest Coverage

    n/a
    		 -15.22

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,191,220.78

    Profits Per Employee

    n/a
    		 $-208,116.88

    Employee Count

    n/a
    		 77

    Asset Turnover

    n/a
    		 1.44

    Inventory Turnover

    n/a
    		 33.48

    Taxes

    Income Tax

    n/a
    		 -74K

    Effective Tax Rate

    n/a
    		 0.34%

    Stock Price Statistics

    The stock price has increased by 22.28% in the last 52 weeks. The beta is 1.37, so Medigus's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.37

    52-Week Price Change

    n/a
    		 22.28%

    50-Day Moving Average

    n/a
    		 2.39

    200-Day Moving Average

    n/a
    		 3.19

    Relative Strength Index (RSI)

    n/a
    		 46.41

    Average Volume (20 Days)

    n/a
    		 13,216

    Income Statement

    In the last 12 months, Medigus had revenue of 91.72M and earned -16.02M in profits. Earnings per share was -9.5.

    Revenue

    n/a
    		 91.72M

    Gross Profit

    n/a
    		 11.84M

    Operating Income

    n/a
    		 -23.32M

    Net Income

    n/a
    		 -16.02M

    EBITDA

    n/a
    		 -12.84M

    EBIT

    n/a
    		 -31.25M

    Earnings Per Share (EPS)

    n/a
    		 -9.5
    Full Income Statement

    Balance Sheet

    The company has 9.36M in cash and 9.79M in debt, giving a net cash position of -429K.

    Cash & Cash Equivalents

    n/a
    		 9.36M

    Total Debt

    n/a
    		 9.79M

    Net Cash

    n/a
    		 -429K

    Retained Earnings

    n/a
    		 -101.61M

    Total Assets

    n/a
    		 63.9M

    Working Capital

    n/a
    		 2.4M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.25M and capital expenditures -1.75M, giving a free cash flow of -7.99M.

    Operating Cash Flow

    n/a
    		 -6.25M

    Capital Expenditures

    n/a
    		 -1.75M

    Free Cash Flow

    n/a
    		 -7.99M

    FCF Per Share

    n/a
    		 -4.74
    Full Cash Flow Statement

    Margins

    Gross margin is 12.91%, with operating and profit margins of -25.43% and -17.47%.

    Gross Margin

    n/a
    		 12.91%

    Operating Margin

    n/a
    		 -25.43%

    Pretax Margin

    n/a
    		 -23.77%

    Profit Margin

    n/a
    		 -17.47%

    EBITDA Margin

    n/a
    		 -14%

    EBIT Margin

    n/a
    		 -25.43%

    FCF Margin

    n/a
    		 -8.72%

    Dividends & Yields

    MDGS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MDGS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 14, 2022. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Nov 14, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -0.23

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist